Your browser doesn't support javascript.
loading
Downregulation of c-Myc expression confers sensitivity to CHK1 inhibitors in hematologic malignancies.
Jiang, Kai-Long; Tong, Le-Xian; Wang, Tao; Wang, Han-Lin; Hu, Xiao-Bei; Xu, Gao-Ya; Jin, Ting-Ting; Kan, Wei-Juan; Xu, Lei; Li, Jia-Nan; Zhang, Kai-Xiang; Song, Ning; Liu, Jie-Yu; Zhang, Meng-Meng; Wu, Wen-Biao; Xiang, Yu-Qi; Gao, An-Hui; Hu, Yong-Zhou; Zhou, Yu-Bo; Liu, Tao; Yang, Jian-Min; Li, Jia.
Afiliación
  • Jiang KL; National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Tong LX; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Wang T; ZJU-ENS Joint Laboratory of Medicinal Chemistry, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
  • Wang HL; Changhai Hospital, Naval Medical University, Shanghai, 200433, China.
  • Hu XB; National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Xu GY; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Jin TT; Shanghai Tech University, Shanghai, 201210, China.
  • Kan WJ; National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Xu L; Zhongshan Institute for Drug Discovery, Institutes of Drug Discovery and Development, Chinese Academy of Sciences, Zhongshan, 528400, China.
  • Li JN; National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Zhang KX; ZJU-ENS Joint Laboratory of Medicinal Chemistry, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
  • Song N; National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Liu JY; National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Zhang MM; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Wu WB; Zhongshan Institute for Drug Discovery, Institutes of Drug Discovery and Development, Chinese Academy of Sciences, Zhongshan, 528400, China.
  • Xiang YQ; National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Gao AH; College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210033, China.
  • Hu YZ; National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Zhou YB; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Liu T; National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Yang JM; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Li J; Shanghai Tech University, Shanghai, 201210, China.
Acta Pharmacol Sin ; 43(1): 220-228, 2022 Jan.
Article en En | MEDLINE | ID: mdl-33782542

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Regulación hacia Abajo / Neoplasias Hematológicas / Inhibidores de Proteínas Quinasas / Proteínas de Unión al ADN Tipo de estudio: Diagnostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Regulación hacia Abajo / Neoplasias Hematológicas / Inhibidores de Proteínas Quinasas / Proteínas de Unión al ADN Tipo de estudio: Diagnostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China